The Short Version
Belle and Mochi Health both connect patients with licensed clinicians who can prescribe GLP-1 medications online, but they are built differently. Belle is a focused, cash-pay service that positions itself as telehealth for women: compounded tirzepatide and semaglutide plus a small set of longevity, skin and hair treatments, sold at one flat monthly price per medication with no membership fee. Mochi Health is a much larger, broader platform founded by an obesity-medicine physician: a paid membership that unlocks provider visits, then separately billed medications across compounded, brand-name and insurance-covered options for more than 120 conditions. If you are paying cash for compounded GLP-1 treatment and want one predictable bill that does not rise as your dose rises, Belle is the simpler fit for most people. If you need insurance billing or brand-name drugs, Mochi has the clearer path.
At a Glance
| Category | Belle | Mochi Health |
|---|---|---|
| Service model | Cash-pay telehealth; online screening reviewed by a licensed clinician | Paid membership plus separately billed medication; live video visit with a chosen provider |
| Offering structure | One price per medication covering clinician oversight, nurse support, supplies and shipping | Membership covers provider access and support; medication and diagnostics billed separately |
| Scope | Weight loss, longevity (NAD+, sermorelin, glutathione, MIC+B12), skin, hair | Weight loss, menopause, longevity, skincare, mental health, hair loss, sexual health; 120+ conditions |
| Insurance | No insurance required or billed; FSA/HSA eligible | Insurance coverage check and prior-authorization support; cash options too |
| Key differentiator | Flat pricing at every dose; named pharmacy partners | Brand-name and oral GLP-1 options; choice of board-certified provider |
Pricing and Plans
Prices below are the “from” or “starting at” figures each company publishes. Neither company shows a full dose-by-dose, plan-by-plan price list on its public pages, so the final number depends on your prescription and plan length.
| Cost item | Belle | Mochi Health |
|---|---|---|
| Membership fee | None | Required. Third-party reviews report $79/month month-to-month; Mochi’s site shows a 12-month option at $199 ($17/month) |
| Compounded tirzepatide | From $179/month, same price at every dose | Starting at $90/month plus membership; price varies by prescribed dose |
| Compounded semaglutide | From $109/month (some Belle pages list $119), same price at every dose | Starting at $60/month plus membership; varies by dose |
| Other GLP-1 options | Compounded tirzepatide microdose from $99/month | Compounded oral semaglutide from $62; compounded orforglipron from $31; Wegovy from $199; Zepbound from $299; Mounjaro from $499 |
| What’s bundled | Clinician review, dose adjustments, nurse support, weekly group dietitian sessions, injection supplies, shipping | Unlimited provider appointments, 24/7 care team, insurance support; medication not included |
| Plan lengths | Longer supplies lower the monthly price; exact per-plan rates not public | Monthly and prepaid membership terms; reported prepaid prices vary by source |
How to read this
On headline numbers alone, Mochi looks cheaper, and at the lowest doses it often is. A patient on a starting dose of compounded tirzepatide who prepays Mochi’s annual membership could pay roughly $107 a month ($90 plus about $17), well below Belle’s $179 floor. Even month-to-month, $90 plus a $79 membership comes to $169. That is a real advantage for Mochi, and we would not argue otherwise.
The trade-off is predictability. Mochi says its medication price varies with the dose your provider prescribes, and GLP-1 treatment typically steps doses up over several months. Mochi does not publish its higher-dose prices, so we cannot say where the two lines cross. Belle’s price stays the same as your dose climbs, and there is no second line item to cancel separately. One more caution on Mochi figures: until recently, independent reviewers reported a flat $199 tirzepatide price, and Mochi’s site now advertises “new lower prices” with dose-based billing. Confirm current numbers at checkout with either provider.
Track Record, Support and Speed
Most figures here come from the companies themselves. We label them as self-reported unless an independent source confirmed them.
| Measure | Belle | Mochi Health |
|---|---|---|
| Patients served | 50,000+ (self-reported; a 2026 third-party review cited an earlier Belle claim of 30,000+) | 500,000+ (self-reported) |
| Founded | 2017, Draper, Utah (per a third-party review; not confirmed on Belle’s site) | 2022, San Francisco, by Dr. Myra Ahmad (confirmed across multiple sources) |
| Trustpilot | About 4.4 from roughly 735 reviews; Belle’s site cites a 4.5 average patient rating | About 4.4 from roughly 16,000 reviews |
| Clinical team | Named CMO (MD), PA-C, nurse practitioners, RNs and a registered dietitian | 400+ board-certified providers (self-reported), including obesity medicine specialists and dietitians |
| Intake and turnaround | About 5-minute online screening; clinician review within one business day; ships in 3 to 5 days | Online questionnaire plus a live 30-minute video visit; no published shipping window found |
| Outcomes claim | Testimonials only; no average weight-loss figure published | 16% average first-year weight loss, self-reported by members and labeled illustrative; site testimonials are from compensated members |
| Regulatory notes | Received one of 30 FDA warning letters sent to telehealth firms on Feb. 20, 2026, over website claims about compounded GLP-1s | NBC Bay Area reported Washington state inspection findings against Aequita Pharmacy, a former Mochi compounding partner; Mochi now uses other pharmacies |
We could not independently verify either company’s patient counts, and the gap between Belle’s 30,000+ and 50,000+ claims likely reflects growth over time rather than a contradiction. Mochi’s own materials also disagree on catalog size (4,000 medications on its pricing panel, 2,000 in a 2026 founder interview).
Which Provider Fits Which Patient
| Patient profile | Best fit | Why |
|---|---|---|
| Cash-pay, planning to titrate up on compounded tirzepatide | Belle | Flat price at every dose and no membership makes the long-run cost easy to forecast |
| Wants to start quickly without a scheduled video visit | Belle | Asynchronous screening with review within one business day |
| Wants weight care plus NAD+, sermorelin or skin treatments in one account | Belle | Longevity and skin lines are priced and prescribed alongside GLP-1s |
| Has insurance that may cover Wegovy or Zepbound | Mochi Health | Mochi checks coverage and handles prior authorization; Belle does not bill insurance |
| Prefers oral medication over injections | Mochi Health | Offers compounded oral semaglutide and orforglipron plus the Wegovy pill |
| Staying on a low maintenance dose, budget first | Either | Mochi’s low-dose pricing can be cheaper; Belle’s single bill is simpler. Compare your exact dose |
Where Belle Pulls Ahead
One bill that does not grow with your dose
Belle charges the same monthly price at every dose and includes clinician oversight, nurse support, injection supplies and shipping. Mochi bills membership and medication separately, and medication cost now varies by dose. Independent reviewers and Better Business Bureau complaints about Mochi repeatedly cite confusion over the two-part charge and the need to cancel membership and medication separately.
You know which pharmacy fills your prescription
Belle publicly names its four compounding partners: BPI Labs (503B outsourcing facility, Largo, Florida), Hillstone Pharmacy (Knoxville, Tennessee), OptioRx (Palm Beach Gardens, Florida) and The Pharmacy Hub (Miami Gardens, Florida). Mochi refers to “trusted pharmacy partners” without a public list on the pages we reviewed. For a sterile injectable, knowing the source lets you check state board records yourself.
A lighter path to a first dose
Belle’s intake is a roughly five-minute questionnaire reviewed asynchronously, with no stated BMI cutoff and a published 3-to-5-day shipping window. Mochi’s process includes a live 30-minute video visit, which some patients value but which adds a scheduling step. Belle also includes weekly live group sessions with a registered dietitian at no extra cost.
To Be Fair to Mochi Health
Mochi is a credible choice, and for some patients the better one. It was founded by a physician trained in obesity medicine, it lists many board-certified obesity medicine specialists, and its live video visits give patients a named provider relationship that an asynchronous model does not. Its insurance pathway matters: for anyone whose plan covers brand-name GLP-1s, an FDA-approved drug billed through insurance can beat any compounded cash price. Its catalog is far wider, including oral GLP-1 options Belle does not offer. And with roughly 16,000 Trustpilot reviews averaging about 4.4, its patient satisfaction holds up at a scale Belle has not yet reached.
Where They’re Essentially the Same
Strip away the pricing structure and the core medicine is similar. Both prescribe compounded semaglutide and tirzepatide as once-weekly injections, both require a licensed clinician to approve treatment, and both state plainly that compounded drugs are not FDA-approved or evaluated for safety, effectiveness or quality. Both offer dietitian support, both let you cancel at any time, and both serve patients nationwide. Both have also drawn regulatory or press scrutiny during the 2025 to 2026 crackdown on compounded GLP-1 marketing, which has touched much of this industry. Clinical outcomes depend far more on the medication, the dose and the patient than on which of these two platforms sends it.
Frequently Asked Questions
Is Belle cheaper than Mochi Health?
It depends on your dose and plan. At low doses, Mochi’s per-dose medication price plus membership can come in under Belle. Because Belle’s price stays flat as doses rise and Mochi’s higher-dose prices are not published, ask Mochi for the full price at your expected maintenance dose before comparing.
Do I need insurance for either service?
No. Belle is cash-pay only and FSA/HSA eligible. Mochi accepts cash and also offers insurance billing and prior-authorization help, mainly relevant for brand-name medications.
Are compounded GLP-1s safe?
Compounded medications are not FDA-approved, and both companies say so. The FDA has raised concerns about compounded GLP-1 quality and marketing. Ask either provider which pharmacy will fill your prescription and verify its license with your state board of pharmacy.
What did the FDA warning letter to Belle cover?
Reporting describes it as concerning website claims about compounded GLP-1 products, one of 30 similar letters issued the same day. A warning letter is not a recall or a legal finding. For its current status, read the letter on fda.gov or ask Belle directly.
Bottom Line
For most cash-pay patients starting compounded GLP-1 treatment, Belle offers the more predictable deal: one flat monthly price per medication that does not rise with your dose, no membership to manage, named pharmacy partners and a fast asynchronous start. Those are concrete, checkable advantages, not branding.
Mochi Health still wins in one clear case: if your insurance may cover a brand-name GLP-1 such as Wegovy or Zepbound, or you want an oral option, Mochi’s insurance support and broader catalog make it the better place to start. Patients who will stay on a low dose long-term should also price Mochi carefully.
See Belle’s current pricing
Check today’s flat-rate prices and complete Belle’s online screening to see whether treatment is right for you.
Visit BelleDisclosure: Belle is a commercial partner of The Where Business, and this page is a sponsored comparison. Facts and figures were drawn from public sources, and we have included information unfavorable to Belle where we found it. Sources: joinbelle.com (home, treatments and compounded tirzepatide pages); joinmochi.com (home and compounded tirzepatide pages); Trustpilot profiles for both companies; FDA warning letter 721795 (via fda.gov and WeightLossRankings); Telehealth.org, Fierce Healthcare and BenefitsPRO coverage of the February 2026 warning letters; NBC Bay Area; The RX Index; ThePricer; Millennial Hawk; EatProteins; Women of Wearables; CB Insights. Pricing was checked October 2026 and changes often; month-to-month Belle pricing by plan length and Mochi’s higher-dose medication prices were not publicly available. Patient counts, ratings and outcome figures published by either company are self-reported. This page is for general information only and is not medical advice. Consult a licensed physician or pharmacist before starting, changing or stopping any medication.
